A restriction fragment length polymorphism for human topoisomerase II: possible relationship to drug-resistance.
In previous studies we used Southern blotting to examine the topoisomerase II locus (on chromosome 17) in human leukemia cell lines and noted a difference in the XmnI restriction endonuclease digestion pattern between an m-AMSA-resistant line and its m-AMSA-sensitive parent line (Zwelling, L. A.; Hinds, M,; Chan, D.; Mayes, J.; Sie, K. L.; Parker, E.; Silberman, L.; Radcliffe, A.; Beran, M.; Blick, M. Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. Journal of Biological Chemistry 264:16411-16420; 1989). We now demonstrate that the variable XmnI digestion pattern represents a normal restriction fragment length polymorphism (RFLP) which is observed in subjects without malignant disease and exhibits an autosomal pattern of inheritance. These data suggest that the previously described deviation in the genomic structure of topoisomerase II in the m-AMSA-resistant cell line did not reflect a new mutation, but rather a reduction to homozygosity at the topoisomerase II locus. This reduction to homozygosity is not due to chromosomal loss, as chromosome 17-specific gene probes clearly identify two chromosome 17's in the sensitive line and four in the resistant line, using chromosome painting with a chromosome 17-specific library. Some other genetic change must be the cause of the resistance of HL-60/AMSA and its topoisomerase II to the inhibiting actions of m-AMSA.
Zwelling
L A
LA
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Mayes
J
J
Deisseroth
K
K
Hinds
M
M
Grant
G
G
Pathak
S
S
Ledley
F D
FD
Vyas
R
R
Hittelman
W
W
D000483:Alleles; D000677:Amsacrine / Q000494:pharmacology; D002886:Chromosomes, Human, Pair 17 / Q000502:physiology; D004247:DNA / Q000235:genetics; D004250:DNA Topoisomerases, Type II / Q000235:genetics*; D004351:Drug Resistance / Q000235:genetics; D014644:Genetic Variation; D006801:Humans; D007942:Leukemia, Experimental / Q000201:enzymology / Q000235:genetics; D007951:Leukemia, Myeloid / Q000201:enzymology / Q000235:genetics; D012150:Polymorphism, Restriction Fragment Length; D014407:Tumor Cells, Cultured
D000677:Amsacrine; D004247:DNA; D004250:DNA Topoisomerases, Type II